CASTLE BIOSCIENCES, INC. Operating Cash Flow
CASTLE BIOSCIENCES, INC. (CSTL) reported Operating Cash Flow of -$6.93 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-30
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $15.20M, a 26.99% decline year-over-year.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$22.13M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $26.93M, a 10.53% increase year-over-year.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $22.63M, a 3.03% decline year-over-year.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2025 was $64.35M, a 0.80% decline from fiscal 2024.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2024 was $64.87M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$5.63M.
- CASTLE BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$41.66M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$6.93M 10-Q · filed 2026-07-30 | $20.00M derived: sum of 3 quarters · filed 2026-07-30 | $42.63M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2026-03-31 | -$22.13M 10-Q · filed 2026-05-06 | $4.80M derived: sum of 2 quarters · filed 2026-05-06 | $27.43M derived: sum of 3 quarters · filed 2026-05-06 | $48.25M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-12-31 | $26.93M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $49.56M derived: sum of 2 quarters · filed 2026-02-26 | $70.38M derived: sum of 3 quarters · filed 2026-07-30 | $64.35M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $22.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $43.45M derived: sum of 2 quarters · filed 2026-07-30 | $37.42M 10-Q · filed 2025-11-03 | $61.78M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-06-30 | $20.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $14.79M 10-Q · filed 2026-07-30 | $39.15M derived: sum of 3 quarters · filed 2026-07-30 | $62.49M derived: sum of 4 quarters · filed 2026-07-30 | ||
| 2025-03-31 | -$6.04M 10-Q · filed 2026-05-06 | $18.33M derived: sum of 2 quarters · filed 2026-05-06 | $41.67M derived: sum of 3 quarters · filed 2026-05-06 | $65.67M derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $24.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $47.70M derived: sum of 2 quarters · filed 2026-02-26 | $71.70M derived: sum of 3 quarters · filed 2026-02-26 | $64.87M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $23.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $47.34M derived: sum of 2 quarters · filed 2025-11-03 | $40.50M 10-Q · filed 2025-11-03 | $59.09M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $24.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $17.16M 10-Q · filed 2025-08-04 | $35.75M derived: sum of 3 quarters · filed 2026-02-26 | $40.76M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | -$6.83M 10-Q · filed 2025-05-05 | $11.75M derived: sum of 2 quarters · filed 2026-02-26 | $16.76M derived: sum of 3 quarters · filed 2026-02-26 | $12.98M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $18.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $23.60M derived: sum of 2 quarters · filed 2026-02-26 | $19.81M derived: sum of 3 quarters · filed 2026-02-26 | -$5.63M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $5.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $1.23M derived: sum of 2 quarters · filed 2024-11-04 | -$24.21M 10-Q · filed 2024-11-04 | -$30.21M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | -$3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$29.23M 10-Q · filed 2024-08-05 | -$35.23M derived: sum of 3 quarters · filed 2025-02-27 | -$40.45M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$25.44M 10-Q · filed 2024-05-02 | -$31.44M derived: sum of 2 quarters · filed 2025-02-27 | -$36.66M derived: sum of 3 quarters · filed 2025-02-27 | -$45.66M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$11.22M derived: sum of 2 quarters · filed 2025-02-27 | -$20.23M derived: sum of 3 quarters · filed 2025-02-27 | -$41.66M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$5.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$14.22M derived: sum of 2 quarters · filed 2023-11-02 | -$35.66M 10-Q · filed 2023-11-02 | -$38.44M derived: sum of 4 quarters · filed 2023-11-02 | ||
| 2022-06-30 | -$9.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | -$30.43M 10-Q · filed 2023-08-02 | -$33.21M derived: sum of 3 quarters · filed 2023-08-02 | -$39.34M derived: sum of 4 quarters · filed 2023-08-02 | ||
| 2022-03-31 | -$21.43M 10-Q · filed 2023-05-03 | -$24.21M derived: sum of 2 quarters · filed 2023-05-03 | -$30.34M derived: sum of 3 quarters · filed 2023-05-03 | -$36.78M derived: sum of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | -$2.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$8.91M derived: sum of 2 quarters · filed 2023-02-28 | -$15.35M derived: sum of 3 quarters · filed 2023-02-28 | -$18.98M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | -$6.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$12.57M derived: sum of 2 quarters · filed 2022-11-02 | -$16.20M 10-Q · filed 2022-11-02 | -$16.63M derived: sum of 4 quarters · filed 2022-11-02 | ||
| 2021-06-30 | -$6.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$10.07M 10-Q · filed 2022-08-08 | -$10.50M derived: sum of 3 quarters · filed 2022-08-08 | -$13.45M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | -$3.63M 10-Q · filed 2022-05-09 | -$4.06M derived: sum of 2 quarters · filed 2022-05-09 | -$7.02M derived: sum of 3 quarters · filed 2022-05-09 | $6.49M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | -$430.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$3.38M derived: sum of 2 quarters · filed 2022-02-28 | $10.12M derived: sum of 3 quarters · filed 2022-02-28 | $9.87M 10-K · filed 2022-02-28 | ||
| 2020-09-30 | -$2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $10.55M derived: sum of 2 quarters · filed 2021-11-08 | $10.29M 10-Q · filed 2021-11-08 | $14.79M derived: sum of 4 quarters · filed 2021-11-08 | ||
| 2020-06-30 | $13.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $13.25M 10-Q · filed 2021-08-09 | $17.74M derived: sum of 3 quarters · filed 2021-08-09 | $18.50M derived: sum of 4 quarters · filed 2021-08-09 | ||
| 2020-03-31 | -$251.00K 10-Q · filed 2021-05-10 | $4.24M derived: sum of 2 quarters · filed 2021-05-10 | $4.99M derived: sum of 3 quarters · filed 2021-05-10 | $5.48M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $5.25M derived: sum of 2 quarters · filed 2021-03-11 | $5.73M derived: sum of 3 quarters · filed 2021-03-11 | $7.01M 10-K · filed 2021-03-11 | ||
| 2019-09-30 | $752.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.23M derived: sum of 2 quarters · filed 2020-11-09 | $2.52M 10-Q · filed 2020-11-09 | $2.52M 10-Q · filed 2019-11-12 | -$688.62K derived: sum of 4 quarters · filed 2020-11-09 | |
| 2019-06-30 | $482.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.77M 10-Q · filed 2020-08-10 | $1.77M 10-Q · filed 2019-09-03 | -$1.44M derived: sum of 3 quarters · filed 2020-08-10 | -$3.32M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $1.29M 10-Q · filed 2020-05-11 | -$1.92M derived: sum of 2 quarters · filed 2020-05-11 | -$3.80M derived: sum of 3 quarters · filed 2020-05-11 | |||
| 2018-12-31 | -$3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$5.09M derived: sum of 2 quarters · filed 2020-03-10 | -$12.29M 10-K · filed 2020-03-10 | |||
| 2018-09-30 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$9.08M 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | -$7.21M 10-Q · filed 2019-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |